tradingkey.logo

GE Healthcare Technologies Inc

GEHC

68.090USD

+0.020+0.03%
收盘 04/29, 16:00美东报价延迟15分钟
31.11B总市值
15.61市盈率 TTM

GE Healthcare Technologies Inc

68.090

+0.020+0.03%
关于 GE Healthcare Technologies Inc 公司
GE HealthCare Technologies Inc. 是一家医疗解决方案提供商,致力于创新医疗技术、药物诊断以及集成的、基于云的人工智能 (AI) 的解决方案、服务和数据分析。其业务部门包括成像、高级可视化解决方案 (AVS)、患者护理解决方案 (PCS) 和药物诊断 (PDx)。其成像部门提供扫描设备、临床应用、服务功能和数字解决方案组合。其 AVS 部门提供超声波、图像引导治疗和介入解决方案,产品组合涵盖整个护理过程,包括某些疾病的筛查、诊断、治疗和监测。其 PCS 部门包括患者监测、麻醉输送和呼吸护理、诊断心脏病学、母婴护理以及耗材和服务。其 PDx 部门开发和生产两种类型的成像剂:造影剂和放射性药物。
公司简介
公司代码GEHC
公司名称GE Healthcare Technologies Inc
上市日期Dec 15, 2022
成立日期2022
CEOMr. Kevin Michael O'Neill
员工数量53000
证券类型Ordinary Share
年结日Dec 15
公司地址500 West Monroe Street
城市CHICAGO
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编60661
电话18337351139
网址https://www.gehealthcare.com
公司代码GEHC
上市日期Dec 15, 2022
成立日期2022
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1.93K%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
9.20K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
8.76K
--
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
8.76K
--
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
7.07K
--
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
6.02K
--
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
165.00
-86.19%
Mr. Lloyd W. Howell, Jr.
Mr. Lloyd W. Howell, Jr.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1.93K%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
9.20K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
8.76K
--
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
8.76K
--
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Total Imaging
8.86B
45.01%
Total Ultrasound
5.13B
26.08%
Total PCS
3.13B
15.89%
Total PDx
2.51B
12.75%
Other
52.00M
0.26%
地区USD
名称
营收
占比
Other
8.92B
45.34%
United States
8.62B
43.80%
China
2.13B
10.85%
业务
地区
业务USD
名称
营收
占比
Total Imaging
8.86B
45.01%
Total Ultrasound
5.13B
26.08%
Total PCS
3.13B
15.89%
Total PDx
2.51B
12.75%
Other
52.00M
0.26%
股东统计
更新时间: 2月21日 周五
更新时间: 2月21日 周五
持股股东
股东类型
持股股东
股东统计
占比
Capital Research Global Investors
13.29%
The Vanguard Group, Inc.
11.43%
BlackRock Institutional Trust Company, N.A.
5.43%
State Street Global Advisors (US)
4.13%
Dodge & Cox
3.64%
Other
62.08%
持股股东
股东统计
占比
Capital Research Global Investors
13.29%
The Vanguard Group, Inc.
11.43%
BlackRock Institutional Trust Company, N.A.
5.43%
State Street Global Advisors (US)
4.13%
Dodge & Cox
3.64%
Other
62.08%
股东类型
股东统计
占比
Investment Advisor
40.35%
Investment Advisor/Hedge Fund
36.91%
Hedge Fund
3.13%
Research Firm
2.52%
Pension Fund
2.22%
Sovereign Wealth Fund
1.44%
Bank and Trust
1.32%
Insurance Company
0.36%
Individual Investor
0.27%
Other
11.47%
机构持股
更新时间: 1月19日 周日
更新时间: 1月19日 周日
报告期
机构数
持股数
持股占比
持股变动
2025Q1
2333
405.87M
88.75%
-9.18M
2024Q4
2344
405.16M
88.60%
-9.34M
2024Q3
2188
396.50M
86.79%
-11.03M
2024Q2
2081
391.61M
85.76%
-10.20M
2024Q1
2000
385.11M
84.39%
-2.29M
2023Q4
1855
385.99M
84.77%
-4.81M
2023Q3
1708
381.18M
83.73%
+1.51M
2023Q2
1574
374.50M
82.34%
-3.85M
2023Q1
1358
378.91M
83.35%
+182.70M
2022Q4
41
468.43M
103.20%
+468.43M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Capital Research Global Investors
60.83M
13.3%
+2.61M
+4.48%
Dec 31, 2024
The Vanguard Group, Inc.
52.34M
11.45%
+2.16M
+4.30%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
24.86M
5.44%
+239.16K
+0.97%
Dec 31, 2024
State Street Global Advisors (US)
18.90M
4.13%
+281.45K
+1.51%
Dec 31, 2024
Dodge & Cox
16.68M
3.65%
+11.87K
+0.07%
Dec 31, 2024
Geode Capital Management, L.L.C.
11.32M
2.48%
+342.82K
+3.12%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
9.45M
2.07%
+126.88K
+1.36%
Feb 28, 2025
Norges Bank Investment Management (NBIM)
6.25M
1.37%
+1.84M
+41.76%
Dec 31, 2024
AllianceBernstein L.P.
6.13M
1.34%
-220.13K
-3.47%
Dec 31, 2024
Hotchkis and Wiley Capital Management, LLC
5.58M
1.22%
-18.35K
-0.33%
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
Langar Global HealthTech ETF
10.47%
Invesco S&P Spin-Off ETF
7.54%
Otter Creek Focus Strategy ETF
4.86%
Absolute Select Value ETF
4.37%
iShares U.S. Medical Devices ETF
3.93%
Capital Group Dividend Value ETF
2.81%
VanEck Morningstar Wide Moat Value ETF
2.69%
VanEck Morningstar Wide Moat ETF
2.38%
VanEck Morningstar Wide Moat Growth ETF
1.99%
Themes US R&D Champions ETF
1.97%
查看更多
Langar Global HealthTech ETF
占比10.47%
Invesco S&P Spin-Off ETF
占比7.54%
Otter Creek Focus Strategy ETF
占比4.86%
Absolute Select Value ETF
占比4.37%
iShares U.S. Medical Devices ETF
占比3.93%
Capital Group Dividend Value ETF
占比2.81%
VanEck Morningstar Wide Moat Value ETF
占比2.69%
VanEck Morningstar Wide Moat ETF
占比2.38%
VanEck Morningstar Wide Moat Growth ETF
占比1.99%
Themes US R&D Champions ETF
占比1.97%
分红派息
近5年累计派现 96.00M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
Sep 22, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 15, 2023
Oct 19, 2023
Jun 23, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 15, 2023
Jul 20, 2023
Apr 25, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Jun 15, 2023 going ex on May 22, 2023
May 23, 2023
Jun 15, 2023
May 22, 2023
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有